These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14593818)

  • 1. Practice guidelines: are they dead on arrival? Yes.
    Amerling R
    Nephrol News Issues; 2003 Oct; 17(11):38-9. PubMed ID: 14593818
    [No Abstract]   [Full Text] [Related]  

  • 2. Practice guidelines: are they dead on arrival? No, but...
    Golper T
    Nephrol News Issues; 2003 Oct; 17(11):40-1. PubMed ID: 14593819
    [No Abstract]   [Full Text] [Related]  

  • 3. A decade of clinical practice guideline development. Part 1: Rationale.
    Goldman RS; Haley W
    Nephrol News Issues; 2003 Oct; 17(11):42-5. PubMed ID: 14593820
    [No Abstract]   [Full Text] [Related]  

  • 4. The MAURO study: multiple intervention and audit in renal diseases to optimize care.
    Zoccali C; Leonardis D; Enia G; Postorino M; Mallamaci F;
    J Nephrol; 2008; 21(1):20-2. PubMed ID: 18264932
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of evidence-based studies in the application of GAPS.
    Strasburger VC
    Am Fam Physician; 1998 Nov; 58(7):1550, 1552. PubMed ID: 9824955
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of progression of kidney disease - CARI guidelines.
    Johnson DW
    Aust Fam Physician; 2007 May; 36(5):353. PubMed ID: 17492072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process.
    Van Wyck D; Eckardt KU; Uhlig K; Rocco M; Levin A
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):8-10. PubMed ID: 17699378
    [No Abstract]   [Full Text] [Related]  

  • 9. [What factors are important for the successful implementation of guidelines?].
    Leentjens AF; Burgers JS
    Tijdschr Psychiatr; 2008; 50(6):329-35. PubMed ID: 18548410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based medicine and practice guidelines: application to genetics.
    Toriello HV; Goldenberg P
    Am J Med Genet C Semin Med Genet; 2009 Aug; 151C(3):235-40. PubMed ID: 19621463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice guidelines in nephrology--for worse or for better.
    Uhlig K; Balk EM; Lau J; Levey AS
    Nephrol Dial Transplant; 2006 May; 21(5):1145-53. PubMed ID: 16520349
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for preventing hospital-acquired infection.
    Harper P
    Nurs Times; 2001 Mar 29-Apr 4; 97(13):34-6. PubMed ID: 11954272
    [No Abstract]   [Full Text] [Related]  

  • 13. Opinions on the content and effects of clinical practice guidelines for CKD: a survey of nephrologists in Australia and New Zealand.
    Irving MJ; Johnson DW; McDonald S; Walker RG; Frommer MS; Craig JC
    Am J Kidney Dis; 2009 Jun; 53(6):1082-90. PubMed ID: 19394725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based emergency medicine. Creating a system to facilitate translation of evidence into standardized clinical practice: a preliminary report.
    Wright SW; Trott A; Lindsell CJ; Smith C; Gibler WB
    Ann Emerg Med; 2008 Jan; 51(1):80-6, 86.e1-8. PubMed ID: 17719134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRD delivery models. Case management from the payor perspective.
    Brandley D
    Nephrol News Issues; 1995 Jun; 9(6):35-6. PubMed ID: 7666932
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic kidney disease-related mineral and bone disorders.
    Argilés A; Vanholder R
    Nephron Clin Pract; 2009; 112(3):c128-36. PubMed ID: 19390213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
    Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; Mehra M; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2007 Jul; 154(1):12-38. PubMed ID: 17584548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface: evidence-based practice guideline for the treatment of chronic kidney disease.
    Sasaki S
    Clin Exp Nephrol; 2009 Dec; 13(6):533. PubMed ID: 19960304
    [No Abstract]   [Full Text] [Related]  

  • 19. KDIGO takes clinical practice guidelines to a global level.
    Neumann ME
    Nephrol News Issues; 2006 Nov; 20(12):40-1, 43, 47. PubMed ID: 17125095
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and economic implications of new strategies for heart failure management in the managed care setting.
    Chase SL; Pickworth KK
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):29S-32S. PubMed ID: 17381372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.